Stories - PrEPWatch

1 November 2024

PxWire Volume 14, Issue No. 4

Check out the latest issue of PxWire here! And see key highlights below: Since 2019, rates of HIV acquisition in Latin America have been trending upward. At the same time, Latin America has taken strides to combat this trend, from increasing PrEP initiation rates to preparing for longer acting PrEP products. On October 2, Gilead…

1 November 2024

PxPulse: The Advocacy Chronicles with Danielle Campbell from PrEP in Black America

In this episode of the Advocacy Chronicles, we’re putting the spotlight on the US, on the dismal statistics on access to PrEP in Black communities, on the state of HIV prevention among Black Americans overall, and the work of one advocacy group— PrEP in Black America (PIBA). Danielle Campbell is one of the founders of…

11 October 2024

Ending HIV: Balancing innovation and affordability with lenacapavir

Lenacapavir (LEN), a groundbreaking HIV-1 capsid inhibitor developed by Gilead Sciences, stands on the brink of revolutionizing HIV prevention. As a potential long-acting PrEP option, it could transform the fight against the epidemic. Yet uncertainty surrounds its future pricing and accessibility, raising urgent questions for the communities hardest hit by HIV. Read the full story…

26 September 2024

Top-Notch Collaboration: Preparing for CAB for PrEP introduction in Namibia

Namibia’s government plans to introduce long-acting injectable cabotegravir (CAB for PrEP) this year. To prepare for CAB for PrEP introduction, the Ministry of Health and Social Services, with support from the PEPFAR- and USAID-funded MOSAIC project, recently conducted a value chain situation analysis. Click here to read the full story on the MOSAIC blog, and…

15 August 2024

PrEP in All Shapes and Sizes at AIDS 2024

The AIDS 2024 conference in Munich showcased major advances across an array of new HIV prevention options. While the results of the Phase III lenacapavir for PrEP trial, PURPOSE 1, took centre stage, more data on cabotegravir for PrEP expanded who can take it, and important conversations were underway on the Dual Prevention Pill. The…

13 August 2024

PxWire Volume 14, Issue No. 3

Check out the latest issue of PxWire here! And see key highlights below: Since the enactment of Uganda’s Anti-Homosexuality Act in March 2023, the number of new PrEP initiations plummeted. An analysis presented at AIDS 2024, found that 69% of 194 countries reviewed have approved at least one PrEP product. However, only 52% of these…

19 July 2024

PxPulse: The Advocacy Chronicles with Ruth Akulu

On this episode of the Advocacy Chronicles: a look at advocacy in Uganda for the Dual Prevention Pill (DPP), a new product combining oral PrEP and oral contraception. Ruth Akulu is a Youth Representative of the Uganda Country Coordinating Mechanism Board for Global Fund, member of the DPP Civil Society Advisory Group, and a 2022…

28 June 2024

Choice Counselling: A conversation that centres the wants and needs of potential PrEP users

As the HIV prevention field continues to grow and introduce new HIV prevention methods such as the PrEP ring and CAB for PrEP, individuals have more options to choose from. But having options alone does not equal having choice. To benefit from the availability of multiple PrEP options, PrEP users need to be able to…

7 June 2024

PxWire Volume 14, Number 2: May 2024

Check out the latest issue of PxWire here! And see key highlights below: New research provides reassuring evidence that oral PrEP can reliably prevent HIV infection in cisgender women even with non-perfect adherence. This year, Canada, Mozambique, Tanzania, and the UK approved injectable cabotegravir, and it’s now under review in Taiwan. Malawi, Zambia and Zimbabwe…

21 May 2024

Early Results from the SEARCH Dynamic Choice Study: More evidence that choice is the key

“This is the evidence we’ve all been waiting for. This is the first time in a community setting that we have scientific evidence that choice matters and choice works.” – AVAC Executive Director, Mitchell Warren When programs offer people-centered choices for what type of PrEP product they want, and where and how to integrate it…